This is an Open-label, Non-randomized Study to Assess the Pharmacokinetics (PK) of VCT220 in Healthy Volunteers When Administered With Rifampin or Itraconazole
Clinical trial NCT07056842 · COMPLETED
Trial details
- NCT number
- NCT07056842
- Sponsor
- Vincentage Pharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-20
- Primary completion
- 2025-08-11
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.